Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

NCT02030301 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Genital Herpes Simplex Type 2

Interventions

BIOLOGICAL: VCL-HB01
BIOLOGICAL: VCL-HM01
BIOLOGICAL: PBS

Sponsor

Vical